Biomarkers Collection

Biomarkers

Biomarkers play a critical role in improving the diagnosis and monitoring of Alzheimer’s disease. These resources offer expert recommendations to help clinicians understand when and how to use biomarker testing in practice.

Explore Current Recommendations for Using Alzheimer's Biomarkers in Clinical Settings.

Guidance on the appropriate use of CSF and blood-based biomarkers to support diagnosis and care planning.

Clinical Practice Guideline: Blood-Based Biomarkers in Specialty Care
Detection and Diagnosis

Clinical Practice Guideline: Blood-Based Biomarkers in Specialty Care

The blood-based biomarker guideline helps clinicians incorporate these emerging tools into the diagnostic process. It reflects the growing evidence that blood tests can support earlier, more accurate diagnosis of Alzheimer’s disease.
Decision Support for the Use of Blood-Based Biomarkers in Primary Care
Detection and Diagnosis

Decision Support for the Use of Blood-Based Biomarkers in Primary Care

A practical tool to help primary care providers consider when and how to integrate blood-based biomarker testing into a comprehensive clinical assessment.
Standardized Blood-Based Biomarkers Sample Handling Workflow
Detection and Diagnosis

Standardized Blood-Based Biomarkers Sample Handling Workflow

A stepwise evidence-based workflow for optimized blood sample collection and processing to ensure reliable Alzheimer’s biomarker measurement.
Evidence-Based Standardized Sample Handling Protocol for Blood-Based AD Biomarker Measurement
Detection and Diagnosis

Evidence-Based Standardized Sample Handling Protocol for Blood-Based AD Biomarker Measurement

Multi-center consensus research article on the development of an evidence-based, standardized pre-analytical sample handling protocol.
Preferred Methodological Reporting for Blood-Based Biomarker Research
Detection and Diagnosis

Preferred Methodological Reporting for Blood-Based Biomarker Research

Preferred reporting practices for blood-based biomarker research to strengthen evidence synthesis and guideline development.
Appropriate Use Criteria: Lumbar Puncture and Cerebrospinal Fluid Testing
Detection and Diagnosis

Appropriate Use Criteria: Lumbar Puncture and Cerebrospinal Fluid Testing

These expert consensus recommendations guide the safe and effective use of cerebrospinal fluid testing to detect Alzheimer’s pathology. Includes criteria for patient selection and clinical application.
ALZPro News and Updates

ALZPro News and Updates

Sign up to receive the latest information about ALZPro, including new tools, resources and updates as they become available.
Subscribe